Citation: Ba. Chapman et al., Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C, INTERN M J, 31(4), 2001, pp. 254-255
Authors:
Chapman, BA
Stace, NH
Edgar, CL
Bartlett, SE
Frampton, CMA
Scahill, SL
Jennings, LC
Citation: Ba. Chapman et al., Interferon-alpha 2a Ribavirin versus Interferon- alpha 2a alone for the retreatment of hepatitis C patients who relapse after a standard course of Interferon, NZ MED J, 114(1128), 2001, pp. 103-104
Authors:
Chapman, BA
Burt, MJ
Frampton, CMA
Collett, JA
Yeo, KHJ
Wilkinson, ID
Cook, HB
Barclay, MJ
Ross, AG
George, PM
Citation: Ba. Chapman et al., The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community, NZ MED J, 113(1118), 2000, pp. 394-396
Citation: Pd. Thomas et al., Use of Tc-99m-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure, GUT, 46(6), 2000, pp. 838-841
Authors:
Collett, JA
Burt, MJ
Frampton, CMA
Yeo, KHJ
Chapman, TM
Buttimore, RC
Cook, HB
Chapman, BA
Citation: Ja. Collett et al., Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies, NZ MED J, 112(1093), 1999, pp. 292-295